Summary
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Renal Failure (ARF) (Acute Kidney Injury). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
AbbVie Inc.
Action Pharma A/S
Am-Pharma B.V.
Complexa, Inc.
SBI Biotech Co., Ltd.
Fresenius SE & Co. KGaA
DURECT Corporation
Baxter International Inc.
Angion Biomedica Corp.
AlloCure Inc.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Acute Renal Failure (ARF) (Acute Kidney Injury) 34
Mar 14, 2016: NeuroVive announces the CiPRICS study enrols 100 patients and reports favourable safety evaluation 34
Mar 14, 2016: Quark Pharmaceuticals Doses First Patient In Two Pivotal Clinical Studies of RNAi-Based Therapeutic QPI-1002 34
Feb 29, 2016: Thrasos Announces Promising Results for Phase II THR-184 Dose Ranging Clinical Study for the Prevention of Acute Kidney Injury (AKI) 35
Clinical Trial Profile Snapshots 36
Appendix 195
Abbreviations 195
Definitions 195
Research Methodology 196
Secondary Research 196
About GlobalData 197
Contact Us 197
Disclaimer 197
Source 198
List of Tables
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 16
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 20
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase, 2016* 23
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 30
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 32
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33
List of Figures
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2016* 15
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Acute Renal Failure (ARF) (Acute Kidney Injury) to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2016* 19
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31
Acute Renal Failure (ARF) (Acute Kidney Injury) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33
GlobalData Methodology 196
